WNDM Medical Inc (WNDM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:WNDM Medical Inc (WNDM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8036
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone bleeding. Its product finds application in all except third degree burns, acute wounds, and chronic wounds. WNDM Medical discovers, develops, and markets advanced wound care products. The company has license agreement with Applied Nutritional for patented technologies and processes related to CellerateRX. It markets its products through independent distributors, healthcare distributors, distributor organizations, and sales representatives. WNDM Medical is headquartered in Fort Worth, Texas, the US.

WNDM Medical Inc (WNDM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
WNDM Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
WNDM Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Wound Management Technologies Raises USD0.2 Million in Rights Offering of Shares 11
Wound Management Technologies Announces Private Placement Of Shares For US$2.4 Million 12
Debt Offering 13
Wound Management Technologies Raises USD0.5 Million in Private Placement of 10% Notes 13
Wound Management Technologies Raises USD0.4 Million in Public Offering of Debentures Due 2015 14
WNDM Medical Inc – Key Competitors 15
WNDM Medical Inc – Key Employees 16
WNDM Medical Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 17
Recent Developments 19
Financial Announcements 19
Jul 12, 2018: WNDM Medical Announces Record Sales for the Second Quarter of 2018 – Up 56% over Second Quarter 2017 19
Mar 29, 2018: Wound Management Technologies Announces Record Annual Sales Ending December 31, 2017 – Up 14% over 2016 20
Jul 20, 2017: Wound Management Technologies Announces Q2 2017 Sales Up 15% over Q2 2016 and All Amortized Debt Retired in the Second Quarter 21
May 17, 2017: Wound Management Issues 2017 10Q and Hires New Strategic Marketing Director 22
Apr 27, 2017: Q1 2017 Sales Up 32% Over Q1 2016, for Wound Management Technologies 23
Feb 14, 2017: Wound Management Technologies Announces Record Quarterly and Annual Sales Ending December 31, 2016 – Up 147% over Q4 2015, and 63% over 2015 24
Corporate Communications 25
Feb 15, 2018: Wound Management Technologies Announces J. Michael Carmena Appointed Chief Executive Officer 25
Mar 08, 2017: Wound Management announces appointment of John Siedhoff as Chairman 26
Other Significant Developments 27
Apr 03, 2018: Wound Management Technologies Changes Name to WNDM Medical 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
WNDM Medical Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
WNDM Medical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
WNDM Medical Inc, Deals By Therapy Area, 2012 to YTD 2018 8
WNDM Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Wound Management Technologies Raises USD0.2 Million in Rights Offering of Shares 11
Wound Management Technologies Announces Private Placement Of Shares For US$2.4 Million 12
Wound Management Technologies Raises USD0.5 Million in Private Placement of 10% Notes 13
Wound Management Technologies Raises USD0.4 Million in Public Offering of Debentures Due 2015 14
WNDM Medical Inc, Key Competitors 15
WNDM Medical Inc, Key Employees 16
WNDM Medical Inc, Subsidiaries 17
WNDM Medical Inc, Joint Venture 17

List of Figures
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
WNDM Medical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
WNDM Medical Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[WNDM Medical Inc (WNDM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adam & Company PLC:企業の戦略・SWOT・財務分析
    Adam & Company PLC - Strategy, SWOT and Corporate Finance Report Summary Adam & Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SMS Pharmaceuticals Ltd (SMSPHARMA):企業の財務・戦略的SWOT分析
    SMS Pharmaceuticals Ltd (SMSPHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • TerSera Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary TerSera Therapeutics LLC (TerSera Therapeutics) is a pharmaceutical company that develops of specialty pharmaceutical products. The company offers ergotamine tartrate sublingual tablets, goserelin acetate implant, zoladex, and zoladex la. It develops products in the therapeutic areas of alle …
  • VIA Technologies, Inc (2388):企業の財務・戦略的SWOT分析
    VIA Technologies, Inc (2388) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Jordan Ahli Bank PSC:企業の戦略・SWOT・財務分析
    Jordan Ahli Bank PSC - Strategy, SWOT and Corporate Finance Report Summary Jordan Ahli Bank PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Clean Energy Fuels Corp (CLNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Clean Energy Fuels Corp (Clean Energy) is an oil and gas company that offers natural gas fuel transportation services. The company’s products fuels, liquefied natural gas, compressed natural gas, renewable natural gas, and bulk fuels. It also provides storage systems, compressors, dispensers …
  • PRA Health Sciences Inc (PRAH):製薬・医療:M&Aディール及び事業提携情報
    Summary PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides clinical development services. The company offers services such as phase I-IV study management, and embedded and functional outsourcing services. It offers solutions in bioanalytical laboratories, biometri …
  • NantKwest Inc (NK):製薬・医療:M&Aディール及び事業提携情報
    Summary NantKwest Inc (NantKwest), a subsidiary of NantWorks LLC, formerly Conkwest Inc, is a clinical-stage immunotherapy company that develops therapeutic treatments for cancer, infectious diseases, and inflammatory diseases. The company utilizes its immuno-oncology NK platform to destroy the tumo …
  • Dako AS-製薬・医療分野:企業M&A・提携分析
    Summary Dako A/S (Dako Denmark), a subsidiary of Agilent Technologies Inc is a diagnostic company. The company’s products include diagnostic antibodies, reagents and kits, software related products, instruments and related products, clone products, and synonym products. It also provides immunohistoc …
  • TearLab Corp (TEAR):医療機器:M&Aディール及び事業提携情報
    Summary TearLab Corp (TearLab) is an ophthalmic device company. It commercializes a proprietary in vitro diagnostic tear testing platform. The company’s flagship TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. The company …
  • Pabulum Limited:企業の戦略・SWOT・財務分析
    Pabulum Limited - Strategy, SWOT and Corporate Finance Report Summary Pabulum Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Shree Rama Newsprint Limited (RAMANEWS):企業の財務・戦略的SWOT分析
    Shree Rama Newsprint Limited (RAMANEWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Colas SA (RE):企業の財務・戦略的SWOT分析
    Colas SA (RE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Solaria Energia y Medio Ambiente S.A. (SLR)-エネルギー分野:企業M&A・提携分析
    Summary Solaria Energia y Medio Ambiente, S.A. (Solaria) is a manufacturer and supplier of photovoltaic (PV) modules and cells, and provider of turnkey projects. It designs, manufactures, supplies, and installs PV and thermal solutions for power generation. Its product portfolio includes PV modules …
  • InnoMedica Holding AG-製薬・医療分野:企業M&A・提携分析
    Summary InnoMedica Holding AG (InnoMedica) discovers and develops therapeutics for the treatment of cancer. The company develops drugs using its proprietary drug delivery technology, Talidox, based on the transport and release of active pharmaceutical agents, locally, at the target area. Its pipelin …
  • Xintela AB (XINT):製薬・医療:M&Aディール及び事業提携情報
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also p …
  • Fidelity Life Assurance of Zimbabwe Ltd:企業の戦略・SWOT・財務情報
    Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report Summary Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Parker Drilling Co (PKD):石油・ガス:M&Aディール及び事業提携情報
    Summary Parker Drilling Co (Parker) is a provider of drilling solutions to the energy industry. It offers services which include land drilling, barge drilling, well services, rig design, construction, operations and maintenance among others. The company provides offshore and onshore contract drillin …
  • Numaligarh Refinery Ltd:企業の戦略的SWOT分析
    Numaligarh Refinery Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Sientra Inc (SIEN):医療機器:M&Aディール及び事業提携情報
    Summary Sientra Inc (Sientra) is a medical device company that manufactures and markets plastic surgery implantable devices. The company’s products comprise breast implants, breast tissue expanders, silicone scar treatment and additional tissue expanders. It offers reconstructive surgery devices suc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆